6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Quarterly Activities Report - March 2026
Just now	Appendix 4C and Quarterly Activities Report - March 2026
20m ago	Landis+Gyr Announces Sale of Rhebo to Everfield
20m ago	Lazard to Acquire Campbell Lutyens, Creating the Global Leader in Private Capital Advisory
30m ago	2026 ESMO GC \| Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations

About

Bioline Rx Ltd (TA:BLRX) — investor relations, events, news, and company updates on 6ix.

Latest News

BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)

BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)

BioLineRx Reports 2025 Financial Results and Provides Corporate Update

BioLineRx to Report 2025 Annual Results on March 23, 2026

BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Financials

Revenue

ILA1.18 M

Market Cap

ILA31.33 M

P/E Ratio

0.00

EPS

0.00

Community Chat

Ask AI